Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al. | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer | 2024 |
|
Adriana Buskin
Dr Emma Scott
Ryan Nelson
Dr Luke Gaughan
Professor Craig Robson
et al. | Engineering prostate cancer in vitro: what does it take? | 2023 |
|
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al. | ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer | 2023 |
|
Dr Emma Scott
Emily Archer Goode
Rebecca Garnham
Dr Kirsty Hodgson
Maggie Orozco Moreno
et al. | ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression | 2023 |
|
Dr Anastasia Hepburn
Dr Cole Sims
Dr Adriana Buskin
Professor Rakesh Heer
| Engineering Prostate Cancer from Induced Pluripotent Stem Cells-New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies | 2020 |
|
Dr Anastasia Hepburn
Emma Curry
Dr Mohammad Moad
Laura Wilson
Parmveer Singh
et al. | Propagation of human prostate tissue from induced pluripotent stem cells | 2020 |
|
Dr Anastasia Hepburn
Laura Wilson
Evangelia Kounatidou
Amy Barnard
Philip Berry
et al. | Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y) | 2019 |
|
Dr Anastasia Hepburn
Laura Wilson
Evangelia Kounatidou
Amy Barnard
Philip Berry
et al. | The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance | 2019 |
|
Dr Anastasia Hepburn
Professor Rakesh Heer
| Urothelial carcinoma stem cells: Current concepts, controversies, and methods | 2018 |
|
Dr Mohammad Moad
Dr Deepali Pal
Dr Anastasia Hepburn
Dr Stuart Williamson
Laura Wilson
et al. | A novel model of urinary tract differentiation, tissue regeneration, and disease: Reprogramming human prostate and bladder cells into induced pluripotent stem cells | 2013 |
|
Dr Stuart Williamson
Dr Anastasia Hepburn
Laura Wilson
Professor Hing Leung
Professor Craig Robson
et al. | Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancer | 2013 |
|
Dr Mohammad Moad
Dr Anastasia Hepburn
Professor Majlinda Lako
Dr Deepali Pal
Professor Rakesh Heer
et al. | Generation of induced pluripotent stem cells from human urinary tract cells | 2013 |
|
Dr Anastasia Hepburn
Dr Luke Gaughan
Dr Stuart Williamson
Dr Deepali Pal
Dr Mohammad Moad
et al. | Investigating the regulation and effects on androgen receptor expression using a novel stem cell environment model of castration resistant prostate cancer | 2013 |
|
Professor Rakesh Heer
Dr Anastasia Hepburn
Dr Stuart Williamson
Dr Amy Kennedy
Dr Amira El-Sherif
et al. | Renal differentiation from adult spermatogonial stem cells | 2013 |
|
Dr Deepali Pal
Dr Mohammad Moad
Dr Anastasia Hepburn
Dr Stuart Williamson
Professor Craig Robson
et al. | Reply from Authors re: "Reprogramming Stromal Cell from the Urinary Tract and Prostate: A Trip to Pluripotency and Back?" | 2013 |
|
Dr Deepali Pal
Dr Mohammad Moad
Dr Anastasia Hepburn
Dr Stuart Williamson
Professor Craig Robson
et al. | Reply from Authors re: Felix Wezel, Jennifer Southgate. Reprogramming Stromal Cells from the Urinary Tract and Prostate: A Trip to Pluripotency and Back? Eur Urol 2013;64:762-4 | 2013 |
|
Dr Anastasia Hepburn
Laura Wilson
Professor Craig Robson
Professor Rakesh Heer
| Stockpiling testosterone; A unique mechanism of progression to castrate resistant disease | 2013 |
|
Dr Stuart Williamson
Dr Anastasia Hepburn
Laura Wilson
Dr Kelly Coffey
Claudia Ryan-Munden
et al. | Human α2β1HI CD133+VE Epithelial Prostate Stem Cells Express Low Levels of Active Androgen Receptor | 2012 |
|
Dr Anastasia Hepburn
Dr Stuart Williamson
Dr Amira El-Sherif
Dr Neha Sahay
Huw Thomas
et al. | Side Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling | 2012 |
|
Dr John Blackwood
Dr Stuart Williamson
Professor Laura Greaves
Laura Wilson
Dr Anastasia Hepburn
et al. | In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells | 2011 |
|
Dr Stuart Williamson
Dr Anastasia Hepburn
Professor Craig Robson
Professor Rakesh Heer
| An update on the prostate cancer stem cell model-CD133+ve stem cell enriched human prostate cells express active androgen receptor | 2011 |
|
Dr Deepali Pal
Dr Stuart Williamson
Professor Craig Robson
Dr Anastasia Hepburn
Professor Rakesh Heer
et al. | Characterising potential for pluripotency induction in human prostate tissue | 2011 |
|
Dr Stuart Williamson
Dr Anastasia Hepburn
Professor Craig Robson
Professor Rakesh Heer
| Comparative meta-analysis of the human prostate stem cell transcriptome demonstrates that progenitor cells are the site of malignant transformation | 2011 |
|
Dr Anastasia Hepburn
Dr Stuart Williamson
Professor Craig Robson
Professor Rakesh Heer
| Side population in human bladder cancer enriches for cancer stem cells that can be targeted by MAPK inhibition | 2011 |
|
Professor Rakesh Heer
Dr Anastasia Hepburn
Dr Tim Cheek
Rob Pickard
Professor Hing Leung
et al. | Phenotypic Modulation of Human Urinary Tract Stroma-derived Fibroblasts by Transforming Growth Factor β3 | 2010 |
|
Dr Anastasia Hepburn
Professor Craig Robson
Professor Nicola Curtin
| Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer | 2007 |
|
Dr Anastasia Hepburn
Daniel Ozanne
Professor David Neal
Professor Craig Robson
| The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway | 2003 |
|
